Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin |
| Type de publication | Journal Article |
| Year of Publication | 2016 |
| Auteurs | Bougnoux M.-E, Dannaoui E., Accoceberry I., Angoulvant A., Bailly E., Botterel F., Chevrier S., Chouaki T., Cornet M., Dalle F., Datry A., Dupuis A., Fekkar A., Gangneux J.P, Guitard J., Hennequin C., Le Govic Y., Le Pape P., Maubon D., Ranque S., Sautour M., Sendid B., Chandenier J. |
| Journal | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Volume | 60 |
| Pagination | 5088-5091 |
| Date Published | AUG |
| Type of Article | Article |
| ISSN | 0066-4804 |
| Résumé | In vitro susceptibility of 933 Candida isolates, from 16 French hospitals, to micafungin was determined using the Etest in each center. All isolates were then sent to a single center for determination of MICs by the EUCAST reference method. Overall essential agreement between the two tests was 98.5% at +/- 2 log(2) dilutions and 90.2% at +/- 1 log(2) dilutions. Categorical agreement was 98.2%. The Etest is a valuable alternative to EUCAST for the routine determination of micafungin MICs in medical mycology laboratories. |
| DOI | 10.1128/AAC.00630-16 |